1. Home
  2. Labeler Index
  3. Upsher-smith Laboratories, Llc
  4. 0245-1073
  5. NDC Package Code: 0245-1073-30 Qudexy XR

NDC Package 0245-1073-30 Qudexy XR

Topiramate Capsule, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0245-1073-30
Package Description:
1 BOTTLE in 1 CARTON / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code:
0245-1073
Proprietary Name:
Qudexy XR
Non-Proprietary Name:
Topiramate
Substance Name:
Topiramate
Usage Information:
Topiramate is used alone and with other medications to prevent and control seizures (epilepsy). It is also used to prevent migraine headaches. Topiramate belongs to a class of drugs known as anticonvulsants.
11-Digit NDC Billing Format:
00245107330
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1494766 - Qudexy XR 100 MG 24HR Extended Release Oral Capsule
  • RxCUI: 1494766 - Sprinkle 24 HR topiramate 100 MG Extended Release Oral Capsule [Qudexy]
  • RxCUI: 1494766 - Qudexy XR 100 MG 24 HR Extended Release Oral Capsule
  • RxCUI: 1494766 - Qudexy XR 100 MG Sprinkle 24 HR Extended Release Oral Capsule
  • RxCUI: 1494769 - topiramate 150 MG Sprinkle 24HR Extended Release Oral Capsule
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Upsher-smith Laboratories, Llc
    Dosage Form:
    Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • TOPIRAMATE 200 mg/1
    • Pharmacologic Class(es):
  • Cytochrome P450 2C19 Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inducers - [MoA] (Mechanism of Action)
  • Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    NDA205122
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    04-11-2014
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0245-1073-901 BOTTLE in 1 CARTON / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0245-1073-30?

    The NDC Packaged Code 0245-1073-30 is assigned to a package of 1 bottle in 1 carton / 30 capsule, extended release in 1 bottle of Qudexy XR, a human prescription drug labeled by Upsher-smith Laboratories, Llc. The product's dosage form is capsule, extended release and is administered via oral form.

    Is NDC 0245-1073 included in the NDC Directory?

    Yes, Qudexy XR with product code 0245-1073 is active and included in the NDC Directory. The product was first marketed by Upsher-smith Laboratories, Llc on April 11, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0245-1073-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0245-1073-30?

    The 11-digit format is 00245107330. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20245-1073-305-4-200245-1073-30